FBR Capital Reiterates Outperform on Cerus (CERS) Following FDA Approval

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. ROIV
6. AAPL
7. HOOD
8. QCOM
9. ACN
10. AZN

Go back to FBR Capital Reiterates Outperform on Cerus (CERS) Following FDA Approval
Cerus Corp (NASDAQ: CERS) Delayed: 2.54 -0.05 (1.93%)
Previous Close $2.59    52 Week High $7.64 
Open $2.56    52 Week Low $4.22 
Day High $2.58    P/E N/A 
Day Low $2.53    EPS $-0.59 
Volume 753,449